卧龙电驱(600580) - 2022 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2022 was ¥3,526,576,421.22, representing an increase of 18.02% compared to the same period last year[5] - The net profit attributable to shareholders was ¥198,013,111.42, reflecting a significant increase of 50.46% year-on-year[5] - The net profit after deducting non-recurring gains and losses was ¥148,118,511.29, which is a 14.12% increase from the previous year[5] - The basic earnings per share (EPS) was ¥0.1524, up by 51.49% compared to the same period last year[5] - Total revenue for Q1 2022 reached CNY 2,824,893,097.83, an increase from CNY 2,445,138,996.60 in Q1 2021, representing a growth of approximately 15.5%[25] - Net profit for Q1 2022 was CNY 203,949,345.93, compared to CNY 141,685,002.74 in Q1 2021, reflecting a year-over-year increase of about 43.9%[22] - Operating profit for Q1 2022 was CNY 248,492,860.26, compared to CNY 188,695,683.73 in the same period last year, indicating a growth of around 31.7%[22] - The company reported a total comprehensive income of CNY 204,601,551.52 for Q1 2022, slightly down from CNY 210,865,014.28 in Q1 2021[23] - Basic earnings per share for Q1 2022 were CNY 0.1524, an increase from CNY 0.1006 in Q1 2021, representing a growth of approximately 51.5%[23] Assets and Liabilities - The total assets at the end of the reporting period were ¥22,271,058,150.60, showing a slight increase of 1.17% from the end of the previous year[6] - The total assets as of March 31, 2022, amounted to RMB 22,271,058,150.60, up from RMB 22,012,647,245.40 at the end of 2021, reflecting a growth of 1.2%[19] - The total current assets increased to RMB 11,783,418,689.63 from RMB 11,610,050,860.17, representing a rise of 1.5%[18] - The total liabilities decreased slightly to RMB 12,989,953,468.64 from RMB 13,018,851,215.33, a decline of 0.2%[20] - The equity attributable to shareholders was ¥8,398,071,224.52, which increased by 2.40% compared to the previous year[6] - The equity attributable to shareholders increased to RMB 8,398,071,224.52 from RMB 8,201,361,442.12, reflecting a growth of 2.4%[20] - The long-term borrowings decreased to RMB 1,704,932,508.28 from RMB 1,800,124,000.80, a reduction of 5.4%[20] - The inventory decreased to RMB 2,962,264,205.42 from RMB 2,998,550,209.79, indicating a decline of 1.2%[18] Cash Flow - The net cash flow from operating activities was ¥209,828,925.99, down by 14.14% year-on-year[5] - The net cash inflow from operating activities was CNY 209,828,925.99, a decrease of 14.1% compared to CNY 244,387,420.13 in the previous year[26] - Total cash inflow from investment activities was CNY 246,511,236.01, compared to CNY 232,417,336.44 in the previous year, reflecting an increase of 6.5%[26] - The net cash outflow from investment activities was CNY -102,043,912.65, a significant decrease from CNY 110,848,463.14 in the previous year[26] - Cash inflow from financing activities totaled CNY 1,125,230,308.29, up from CNY 872,068,618.94, marking an increase of 29.0%[26] - The net cash flow from financing activities was CNY 3,635,782.10, a recovery from a net outflow of CNY -370,808,517.14 in the previous year[26] - The net increase in cash and cash equivalents was CNY 103,593,652.73, compared to a decrease of CNY -34,846,400.40 in the previous year[27] - The ending balance of cash and cash equivalents was CNY 2,162,306,020.12, an increase from CNY 1,942,716,651.73 in the previous year[27] - The total cash inflow from operating activities was CNY 3,370,987,344.72, compared to CNY 2,670,162,337.89 in the previous year, indicating a growth of 26.2%[26] Research and Development - Research and development expenses increased by 31.94%, indicating a rise in investment in innovation[7] - Research and development expenses increased to CNY 122,202,315.69 in Q1 2022, up from CNY 92,622,112.65 in Q1 2021, marking a rise of approximately 31.9%[22] Non-Recurring Gains and Losses - Non-recurring gains and losses totaled ¥49,894,600.13, with significant contributions from government subsidies and asset disposals[7]